
The Liver Summit (TLS 2026) is a one-day, high-impact CME conference bringing together leaders in hepatology, metabolic medicine, obesity care, primary care, and allied health. Designed to deliver practical, patient-centered, clinically actionable education, TLS 2026 focuses on the rapidly evolving intersection of liver disease and metabolic health, a space increasingly defining modern hepatology.
The program features nationally recognized experts and multidisciplinary sessions spanning steatotic liver disease, cardiometabolic risk, obesity care, general hepatology updates, and the role of AI in clinical practice. Attendees will gain up-to-date insights on MASLD, MetALD, alcohol and nutrition-related liver disease, metabolic comorbidity management, weight wellness strategies, and the newest therapeutic pipelines.
Throughout the day, participants will engage in expert panels, “How I Treat” discussions, and a patient-perspective session highlighting the lived experience of liver disease. A dedicated CME-eligible industry symposium, structured networking opportunities, and a closing reception provide an ideal setting for connection and collaboration across specialties.
Whether you are a hepatologist, gastroenterologist, obesity medicine clinician, primary-care provider, APP, dietitian, or researcher, TLS 2026 offers a comprehensive, forward-looking overview of the key trends shaping liver and metabolic health today—and equips you with the practical tools to apply these insights in your clinical practice.
Event Directors
Glenda Delgado Ramos
Oncologist focused on breast cancer with extensive clinical experience. Leads initiatives on health disparities and community outreach exclusively for the Texas Liver Care Foundation, with no role in Texas Liver Health or Evidentis Clinical Research. Supports board development and program oversight.
Thomas G. Cotter
Shaunach Talley
DFW-based operations professional with 20+ years of experience in product development and global sourcing in the consumer goods industry. Oversees financial record-keeping, budgeting, and reporting; manages fundraising operations; ensures financial accountability and compliance.
Event Participants
Thomas G. Cotter
Shaunach Talley
DFW-based operations professional with 20+ years of experience in product development and global sourcing in the consumer goods industry. Oversees financial record-keeping, budgeting, and reporting; manages fundraising operations; ensures financial accountability and compliance.
Event Agenda
Saturday, May 16, 2026
7:00 AM Breakfast and Registration* - Las Colinas Foyer
7:30 AM - 8:15 AM Las Colinas Ballroom Reach For Treatment Goals Together George Salem, MD and Brooke Hodnick, PA Industry-Sponsored Event* Sponsored by Eli Lilly and Co
8:15 AM - 8:45 AM Break and Visit Exhibits* - Las Colinas Foyer
8:45 AM - 8:50 AM Program Overview - Las Colinas Ballroom
Session III - Las Colinas Ballroom
8:50 AM - 9:20 AM What We Don’t Know About Celiac Disease Lawrence Schiller, MD
9:20 AM - 9:50 AM Endoscopic Challenges with GLP-1 Agonists Harish Gagneja, MD
9:50 AM - 10:20 AM Latest Updates in Irritable Bowel Syndrome (IBS) Brooks Cash, MD
10:20 AM - 10:45 AM Q&A / Panel Discussion
10:45 AM - 11:00 AM Break and Visit Exhibits* - Las Colinas Foyer
11:00 AM - 12:00 PM Parallel Session (Select One) GI Woes from Head to Toe - Carrolton Inflammatory Bowel Disease - Brown Obesity and Steatosis - Britain Chronic Liver Disease - Frisco
12:00 PM - 12:15 PM Lunch and Visit Exhibits* - Las Colinas Foyer
12:15 PM - 1:00 PM Las Colinas Ballroom Rezdiffra: Unlocking The Potential Of A Liver-Directed Treatment Reed Hogan II, MD Industry-Sponsored Event* Sponsored by Madrigal Pharmaceuticals
1:00 PM - 1:30 PM Break and Visit Exhibits* - Las Colinas Foyer
Session IV - Las Colinas Ballroom
1:30 PM - 2:00 PM NITs for Risk Stratification in Steatotic Liver Disease Lisa VanWagner, MD
2:00 PM - 2:30 PM New and Emerging Treatments for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Mack Mitchell, MD
2:30 PM - 2:55 PM Complications of Portal Hypertension Kimberly Brown, MD
2:55 PM - 3:20 PM Screening and Management of Hepatocellular Carcinoma Sumeet Asrani, MD
3:20 PM - 3:35 PM Q&A / Panel Discussion
3:35 PM - 3:45 PM Break and Visit Exhibits* - Las Colinas Foyer
Session V - Las Colinas Ballroom
3:45 PM - 4:15 PM Positioning Therapies in Inflammatory Bowel Disease (IBD) David Rubin, MD
4:15 PM - 4:45 PM Managing the Pregnant Patient with IBD Siobhan Proksell, MD
4:45 PM - 5:15 PM Preventive Care in IBD Freddy Caldera, DO, PhD
5:15 PM - 5:30 PM Q&A / Panel Discussion
5:30 PM - 5:40 PM Meeting Wrap-up
Friday, May 15, 2026
11:00 AM Lunch and Registration - Las Colinas Foyer
11:30 AM - 12:15 PM Las Colinas Ballroom Tremfya for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis Tauseef Ali, MD Industry-Sponsored Event* Sponsored by Johnson & Johnson
12:15 PM - 12:45 PM Break and Visit Exhibits* - Las Colinas Foyer
12:45 PM - 1:00 PM Program Overview - Las Colinas Ballroom
Session I - Las Colinas Ballroom
1:00 PM - 1:25 PM Achalasia Versus EGJ Outflow Obstruction Stuart Spechler, MD
1:25 PM - 1:50 PM Surveillance for Barrett's Esophagus Sachin Wani, MD
1:50 PM - 2:15 PM Management of Obesity in 2026 Tonia Vinton, MD
2:15 PM - 2:30 PM Q&A / Panel Discussion
2:30 PM - 2:45 PM Break and Visit Exhibits* - Las Colinas Foyer
Session II - Las Colinas Ballroom
2:45 PM - 3:10 PM Reducing Alcohol Use in Patients with Steatotic Liver Disease Jan Petrasek, MD
3:10 PM - 3:35 PM Updates in Primary Biliary Cholangitis John Vierling, MD
3:35 PM - 4:00 PM Diagnosis and Management of Hereditary Alpha-1 Antitrypsin (A1AT) Deficiency Paul Kwo, MD
4:00 PM - 4:15 PM Q&A / Panel Discussion
4:15 PM - 4:45 PM Dinner and Visit Exhibits* - Las Colinas Foyer
4:45 PM - 5:30 PM Las Colinas Ballroom IQIRVO & Bylvay: Discover Treatment Options For Your Patients Parvez Mantry, MD Industry-Sponsored Event* Sponsored by Ipsen Biopharmaceuticals
5:30 PM - 6:30 PM Conference Reception* - Las Colinas Foyer





